跳转至内容
Merck
CN

C8249

Sigma-Aldrich

小豆蔻明

≥98% (HPLC),  glycogen synthase kinase 3 (GSK3) inhibitor, powder

别名:

(2E)-1-(2,4-二羟基-6-甲氧基苯基)-3-苯基-2-丙烯-1-酮, (8CI);川陈皮素查尔酮, (E)-2′,4′-二羟基-6′-甲氧基查尔酮

登录查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
C16H14O4
化学文摘社编号:
分子量:
270.28
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

小豆蔻明, ≥98% (HPLC)

质量水平

方案

≥98% (HPLC)

表单

powder

颜色

light yellow to dark brown

溶解性

DMSO: ≥20 mg/mL

储存温度

room temp

SMILES字符串

O=C(/C=C/C1=CC=CC=C1)C2=C(O)C=C(O)C=C2OC

InChI

1S/C16H14O4/c1-20-15-10-12(17)9-14(19)16(15)13(18)8-7-11-5-3-2-4-6-11/h2-10,17,19H,1H3/b8-7+

InChI key

NYSZJNUIVUBQMM-BQYQJAHWSA-N

正在寻找类似产品? 访问 产品对比指南

应用

小豆蔻明已被用作糖原合酶激酶3(GSK3)抑制剂,用于研究其对植入前人胚胎中β-连环蛋白功能缺失和获得(loss and gain-of-function)的影响。
小豆蔻明已被用作高效液相色谱(HPLC)分析金合欢(acacia)蜂蜜样品中酚类化合物中的标准品。

生化/生理作用

小豆蔻醚 (Cardamonin) 是一种来自豆蔻属(姜科植物)的查耳酮。
小豆蔻醚 (Cardamonin) 是一种来自豆蔻属(姜科植物)的植物。小豆蔻醚通过抑制 Wnt/β-连环蛋白 信号通路抑制黑素细胞色素沉着。小豆蔻醚通过蛋白酶体介导降解 β-连环蛋白(GSK-3β 非依赖性途径)抑制 Wnt/β-连环蛋白信号通路。研究表明,小豆蔻醚通过抑制 NF-kB 核转位和 Ik-Ba 磷酸化而具有抗炎活性。

象形图

Exclamation mark

警示用语:

Warning

危险声明

危险分类

Acute Tox. 4 Oral

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Ying Liu et al.
BMC complementary medicine and therapies, 23(1), 336-336 (2023-09-26)
mTORC1 (mechanistic target of rapamycin complex 1) is associated with lymphoma progression. Oncogenic RRAGC (Rag guanosine triphosphatase C) mutations identified in patients with follicular lymphoma facilitate the interaction between Raptor (regulatory protein associated with mTOR) and Rag GTPase. It promotes
Bokyung Sung et al.
PloS one, 8(5), e64118-e64118 (2013-05-22)
Bone loss/resorption or osteoporosis is a disease that is accelerated with aging and age-associated chronic diseases such as cancer. Bone loss has been linked with human multiple myeloma, breast cancer, and prostate cancer and is usually treated with bisphosphonates, and
Peiguang Niu et al.
Oncology letters, 15(3), 3991-3997 (2018-02-20)
The mammalian target of rapamycin (mTOR) is well-known as a promising therapeutic target in various cancer cells. mTOR activation decreases the sensitivity of ovarian cancer to cisplatin. Cardamonin inhibits the proliferation of various cancer cells by mTOR suppression. The present
Qiushi Xu et al.
Frontiers in pharmacology, 11, 601716-601716 (2020-12-29)
Cardamonin (CD), a naturally occurring chalcone derived from the Alpinia species, has been shown to exert antioxidant and anti-inflammatory activity, but its role in the prevention of acetaminophen- (APAP-) induced hepatotoxicity remains elusive. The objective of this study was to
Deyong Jia et al.
Oncotarget, 7(1), 771-785 (2015-10-28)
The failure of cytotoxic chemotherapy in breast cancers has been closely associated with the presence of drug resistant cancer stem cells (CSCs). Thus, screening for small molecules that selectively inhibit growth of CSCs may offer great promise for cancer control

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持